Page last updated: 2024-09-03

candoxatrilat and Hypoxia

candoxatrilat has been researched along with Hypoxia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hughes, JM; Winter, RJ; Zhao, L2
Hughes, JM; Krausz, T; Winter, RJ; Zhao, L1

Other Studies

3 other study(ies) available for candoxatrilat and Hypoxia

ArticleYear
Reversal of pulmonary vascular remodelling following hypoxic exposure: no effect of infusion of atrial natriuretic factor and neutral endopeptidase inhibitor.
    Cardiovascular research, 1994, Volume: 28, Issue:4

    Topics: Animals; Atrial Natriuretic Factor; Cyclohexanecarboxylic Acids; Hematocrit; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Muscle, Smooth, Vascular; Neprilysin; Rats; Rats, Wistar; Time Factors

1994
Effects of natriuretic peptides and neutral endopeptidase 24.11 inhibition in isolated perfused rat lung.
    The American review of respiratory disease, 1992, Volume: 146, Issue:5 Pt 1

    Topics: Animals; Atrial Natriuretic Factor; Cyclohexanecarboxylic Acids; Drug Evaluation, Preclinical; Drug Interactions; Hypoxia; Male; Natriuretic Peptide, Brain; Neprilysin; Nerve Tissue Proteins; Pulmonary Artery; Pulmonary Circulation; Pulmonary Wedge Pressure; Rats; Rats, Wistar; Vasoconstriction; Vasodilation

1992
Neutral endopeptidase 24.11 inhibition reduces pulmonary vascular remodeling in rats exposed to chronic hypoxia.
    The American review of respiratory disease, 1991, Volume: 144, Issue:6

    Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Cyclohexanecarboxylic Acids; Hypertension, Pulmonary; Hypoxia; Male; Neprilysin; Pulmonary Artery; Rats; Rats, Inbred Strains

1991